Skip to main content
Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
43.31
+0.42 (0.98%)
At close: Nov 13, 2026, 4:00 PM EST
43.12
-0.19 (-0.44%)
After-hours: Nov 13, 2026, 7:30 PM EST

Spruce Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--4.9110.09--
Revenue Growth
---51.32%---
Gross Profit
-45.28-13.62-41.51-39.34-35.2-
Operating Income
-64.88-28.61-56.15-51.99-47.28-42.07
Net Income
-67.15-38.97-53.04-47.92-46.18-42.29
Earnings Per Share
-33.82-50.83-96.40-93.32-147.21-135.78
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
87.6948.9138.7596.3479.0888.97
Total Debt
8.320.742.774.616.326.53
Net Cash (Debt)
79.3748.1735.9991.7372.7682.44
Net Cash Growth
751.51%33.85%-60.77%26.07%-11.74%-45.32%
Net Cash Per Share
39.9862.8465.42178.65231.95264.66

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-51.07-33.33-55.96-33.28-41.68-35.88
Capital Expenditures
-0.15---0.01-0.01-0.09
Free Cash Flow
-51.21-33.33-55.96-33.28-41.69-35.97
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
---1143.37%-515.34%--
Pretax Margin
---1079.94%-474.96%--
Profit Margin
---1079.94%-474.96%--
FCF Margin
---1139.56%-329.88%--

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--3.5311.82--